AstraZeneca, Torrent Settle Time-Release Seroquel IP Row

Law360, New York (February 08, 2013, 7:18 PM ET) -- AstraZeneca Pharmaceuticals LP and Torrent Pharmaceuticals Ltd. on Friday settled a patent infringement suit over AstraZeneca’s drug Seroquel XR after Torrent agreed to delay their production of a generic, according to a motion filed in New Jersey federal court.

As part of the consent judgment, Torrent admitted AstraZeneca’s patent on the anti-depressant is enforceable and valid, and agreed not to produce a generic version of Seroquel XR until November 2016.

Representatives for the parties did not immediately respond to requests for comment Friday.

AstraZeneca filed suit...
To view the full article, register now.